Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC

NCT03361800 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Funding withdrawn.

Conditions

Breast Cancer
Invasive Breast Cancer
ER-Negative PR-Negative HER2-Negative Breast Cancer

Interventions

DRUG: Entinostat

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]